ROLE OF ANTILEUKOTRIENE DRUGS IN ACHIEVEMENT OF BRONCHIAL ASTHMA CONTROL

Abstract

Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course. Heterogeneity in asthma is manifested in relation to the age of the onset, triggers, pattern of inflammation, severity of clinical manifestations and response to therapy. Cysteinyl leukotrienes play an important role in the pathogenesis of asthma and allergic rhinitis (AR), therefore, antagonists of leukotriene receptors approved themselves as effective drugs in controlling asthma therapies, particularly for some phenotypes. This review article is devoted to the modern role of Montelukast in asthma treatment.

Keywords

• bronchial asthma
• phenotypes of asthma
• montelukast